← back to search

Ana Victoria Lechuga‐Vieco

Institute for Research in Biomedicine · GB

Area of research

Molecular Biology · Epidemiology

Research interest

Research interests include Mitochondrial Function and Pathology, Autophagy in Disease and Therapy, Nanoparticle-Based Drug Delivery, and Cancer, Hypoxia, and Metabolism.

h-index

23

citations

3,104

works

57

NIH funding

—

primary concept

Chemistry

email

✉ Find email ↗

Recent publications

Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease

Nature Communications 2022cited by 24position: middledoi

A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart

Cell 2020cited by 718position: middledoi

Na+ controls hypoxic signalling by the mitochondrial respiratory chain

Nature 2020cited by 232position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2022–2022)Mei Tian · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)— · 1 papers (2022–2022)Qing Zhong · Nanjing Agricultural University1 papers (2022–2022)Linsen Li · Shanghai Jiao Tong University1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)Kwee Yong · Peter MacCallum Cancer Centre1 papers (2022–2022)Yanping Wang · Center for Cancer Research1 papers (2022–2022)Shuhao Zhang · The University of Texas Southwestern Medical Center1 papers (2022–2022)Yunsen Li · Soochow University1 papers (2022–2022)Jian‐Qing Mi · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)Selina J Chavda · University College London Hospitals NHS Foundation Trust1 papers (2022–2022)Erdinç Sezgin · Science for Life Laboratory1 papers (2022–2022)Hanlin Zhang · Howard Hughes Medical Institute1 papers (2022–2022)Claire M. Edwards · George Washington University1 papers (2022–2022)Hantao Lou · Nankai University1 papers (2022–2022)Yi‐Huah Lee · National Taiwan University1 papers (2022–2022)Anna Katharina Simon · Max Delbrück Center1 papers (2022–2022)— · 1 papers (2022–2022)